Literature DB >> 22949495

Left ventricular ejection fraction assessment among patients with acute myocardial infarction and its association with hospital quality of care and evidence-based therapy use.

Amy Leigh Miller1, Chadi Dib, Li Li, Anita Y Chen, Ezra Amsterdam, Marjorie Funk, Jorge F Saucedo, Tracy Y Wang.   

Abstract

BACKGROUND: The left ventricular ejection fraction (LVEF) has prognostic and therapeutic utility after acute myocardial infarction (AMI). Although LVEF assessment is a key performance measure among AMI patients, contemporary rates of in-hospital assessment and its association with therapy use have not been well characterized. METHODS AND
RESULTS: We examined rates of in-hospital LVEF assessment among 77 982 non-ST-elevation myocardial infarction patients and 50 863 ST-elevation myocardial infarction patients in Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines between January 2007 and September 2009, after excluding patients who died in-hospital or who were transferred to another acute care facility, discharged to end-of-life care, or had missing LVEF assessment status. LVEF assessment increased significantly over time, with higher rates among ST-elevation myocardial infarction than non-ST-elevation myocardial infarction patients (95.1% versus 91.6%; P<0.001). Excluding patients with prior heart failure did not alter these observations. Significant interhospital variability in LVEF assessment rates was observed. Compared with patients with in-hospital LVEF assessment, patients who did not have LVEF assessed were older and more likely to have clinical comorbidities. In multivariable modeling, lower overall hospital quality of AMI care was also associated with lower likelihood of LVEF assessment (odds ratio for failure to assess LVEF, 1.09; 95% confidence interval, 1.05-1.13 per 10% decrease in defect-free care). Patients with in-hospital LVEF assessment were more likely to be discharged on evidence-based secondary prevention medication therapies compared with patients without LVEF assessment.
CONCLUSIONS: The assessment of LVEF among patients with AMI has improved significantly over time, yet significant interhospital variability exists. Patients who did not have in-hospital LVEF assessment were less likely to receive evidence-based medications at discharge. These patients represent targets for future quality improvement efforts.

Entities:  

Mesh:

Year:  2012        PMID: 22949495     DOI: 10.1161/CIRCOUTCOMES.112.965012

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


  12 in total

1.  Identifying the most important ECG predictors of reduced ejection fraction in patients with suspected acute coronary syndrome.

Authors:  Mohammad Alhamaydeh; Richard Gregg; Abdullah Ahmad; Ziad Faramand; Samir Saba; Salah Al-Zaiti
Journal:  J Electrocardiol       Date:  2020-06-05       Impact factor: 1.438

2.  Quality Control and Reproducibility in M-Mode, Two-Dimensional, and Speckle Tracking Echocardiography Acquisition and Analysis: The CARDIA Study, Year 25 Examination Experience.

Authors:  Anderson C Armstrong; Erin P Ricketts; Christopher Cox; Paul Adler; Alexander Arynchyn; Kiang Liu; Ellen Stengel; Stephen Sidney; Cora E Lewis; Pamela J Schreiner; James M Shikany; Kimberly Keck; Jamie Merlo; Samuel S Gidding; João A C Lima
Journal:  Echocardiography       Date:  2014-11-09       Impact factor: 1.724

3.  Reference ranges of left ventricular structure and function assessed by contrast-enhanced cardiac MR and changes related to ageing and hypertension in a population-based study.

Authors:  Robin Bülow; Till Ittermann; Marcus Dörr; Axel Poesch; Sönke Langner; Henry Völzke; Norbert Hosten; Marc Dewey
Journal:  Eur Radiol       Date:  2018-03-14       Impact factor: 5.315

4.  Effects of clinical depression on left ventricular dysfunction in patients with acute coronary syndrome.

Authors:  Jacob Sama; Dhananjay Vaidya; Monica Mukherjee; Marlene Williams
Journal:  J Thromb Thrombolysis       Date:  2021-04       Impact factor: 2.300

5.  National quality assessment evaluating spironolactone use during hospitalization for acute myocardial infarction (AMI) in China: China Patient-centered Evaluation Assessment of Cardiac Events (PEACE)-Retrospective AMI Study, 2001, 2006, and 2011.

Authors:  Wenchi Guan; Karthik Murugiah; Nicholas Downing; Jing Li; Qing Wang; Joseph S Ross; Nihar R Desai; Frederick A Masoudi; John A Spertus; Xi Li; Harlan M Krumholz; Lixin Jiang
Journal:  J Am Heart Assoc       Date:  2015-06-12       Impact factor: 5.501

6.  Treatment Outcomes of Patients with Acute Coronary Syndrome Admitted to Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.

Authors:  Kassahun Bogale; Desalew Mekonnen; Teshome Nedi; Minyahil Alebachew Woldu
Journal:  Clin Med Insights Cardiol       Date:  2019-04-17

7.  Trends in High- and Low-Value Cardiovascular Diagnostic Testing in Fee-for-Service Medicare, 2000-2016.

Authors:  Vinay Kini; Timea Viragh; David Magid; Frederick A Masoudi; Ali Moghtaderi; Bernard Black
Journal:  JAMA Netw Open       Date:  2019-10-02

8.  Differences in High- and Low-Value Cardiovascular Testing by Health Insurance Provider.

Authors:  Vinay Kini; Bridget Mosley; Sridharan Raghavan; Prateeti Khazanie; Steven M Bradley; David J Magid; P Michael Ho; Frederick A Masoudi
Journal:  J Am Heart Assoc       Date:  2021-01-28       Impact factor: 5.501

9.  Cardiovascular Events and Long-Term Risk of Sudden Death Among Stabilized Patients After Acute Coronary Syndrome: Insights From IMPROVE-IT.

Authors:  Christopher B Fordyce; Robert P Giugliano; Christopher P Cannon; Matthew T Roe; Abhinav Sharma; Courtney Page; Jennifer A White; Yuliya Lokhnygina; Eugene Braunwald; Michael A Blazing
Journal:  J Am Heart Assoc       Date:  2022-02-03       Impact factor: 6.106

10.  Temporal Trends in Heart Failure Incidence Among Medicare Beneficiaries Across Risk Factor Strata, 2011 to 2016.

Authors:  Rohan Khera; Nitin Kondamudi; Lin Zhong; Muthiah Vaduganathan; Joshua Parker; Sandeep R Das; Justin L Grodin; Ethan A Halm; Jarett D Berry; Ambarish Pandey
Journal:  JAMA Netw Open       Date:  2020-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.